Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis (Q44557788)

4 December 2017

Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis (English)

1 reference

4 December 2017

1 reference

1 reference

Joel B Epstein

1

1 reference

PubMed ID

12931087

4 December 2017

Pamela J Hancock

series ordinal

2

1 reference

PubMed ID

12931087

4 December 2017

Stephen Nantel

series ordinal

3

1 reference

4 December 2017

1 August 2003

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

4 December 2017

1 reference

4 December 2017

96

1 reference

4 December 2017

2

1 reference

4 December 2017

154-163

1 reference

Oral cavity complications of bone marrow transplantation

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Fever and infection in leukemic patients.A study of 494 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Fungal infections in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Oral complications of bone marrow transplantation in adults with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Esophageal infections in immunosuppressed patients after marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Treatment of mycoses in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Infectious complications in the child with cancer. II. Management of specific infectious organisms

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

The outlook for antifugal prophylaxis in the compromised host

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Candida colonization and systemic infection in neutropenic patients. A retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Carriage of Candida species and C albicans biotypes in patients undergoing chemotherapy or bone marrow transplantation for haematological disease

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Hepatosplenic candidiasis: successful treatment with fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Hepatic candidiasis in cancer patients: the evolving picture of the syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Hepatosplenic candidiasis in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Adherence of Candida albicans to buccal and vaginal epithelial cells: ultrastructural observations

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Cell proliferation and ageing in mouse colon. II. Late effects of repeated x-irradiation in young and old mice

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

1 reference

7 January 2021

Fungal complications of transplantation: diagnosis, treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Residual radiation injury: hematopoietic and gastrointestinal involvement in relation to age

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Chemotherapy-associated oral infections in adults with solid tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Orofacial aspergillosis in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

A long-term prospective clinical study of oral complications during conventional chemotherapy for acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Predictive value of surveillance cultures for systemic infection due to Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

The value of fungal surveillance cultures as predictors of systemic fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Candida tropicalis: A Major Pathogen in Immunocompromised Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Fungal infections after bone marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Prophylaxis of candidiasis in patients with leukemia and bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Antifungal Prophylaxis during Neutropenia or Allogeneic Bone Marrow Transplantation: What is the State of the Art?

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Experimental Hematogenous Endophthalmitis Due to Candida: Species Variation in Ocular Pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

The pathogenicity of Candida tropicalis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Oral infections and septicemia in immunocompromised patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

The oral flor as a source of septicemia in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Alterations in the oral mucosa caused by chemotherapeutic agents. A histologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

The effect of cytotoxic therapy on saliva and oral flora

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Lessons learned from surveillance cultures in patients with acute nonlymphocytic leukemia. Usefulness for epidemiologic, preventive and therapeutic research

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Surveillance cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Oral mucositis after bone marrow transplantation. A marker of treatment toxicity and predictor of hepatic veno-occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Variables predicting oral mucosal lesions in allogenic bone marrow recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Evaluation of nystatin in prevention and elimination of oropharyngeal Candida in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Antifungal Agents Used in Systemic Mycoses Activity and Therapeutic Use

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Fluconazole-resistant candidosis in an HIV cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Development of Fluconazole Resistance inCandida albicansCausing Disseminated Infection in a Patient Undergoing Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Systemic antifungal agents. What is in the pipeline?

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

In vitro antifungal properties of mouthrinses containing antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Effects of chlorhexidine diacetate on Candida albicans, C. glabrata and Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Oral Candida albicans in bone marrow transplant patients given chlorhexidine rinses: occurrence and susceptibilities to the agent

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900296-8

7 January 2021

10.1016/S1079-2104(03)00296-8

Identifiers

DOI

1 reference

4 December 2017

1 reference

PubMed ID

12931087